Springer

SHERPA: Unknown

People

  1. Brennan
    Brennan
  2. Coit
    Coit
  3. Hudis
    Hudis
  4. Paty
    Paty
  5. Brady
    Brady
  6. Cody
    Cody
  7. Heerdt
    Heerdt
  8. Jarnagin
    Jarnagin
  9. Kelsen
    Kelsen
  10. Panageas
    Panageas

Groups

  1. Surgery (46)
  2. Survivorship Research (33)
  3. Department of Medicine (29)
  4. Solid Tumor Oncology Division (20)
  5. Sloan Kettering Institute Faculty (19)
  6. Molecular Pharmacology and Chemistry Program Faculty (16)
  7. Sarcoma Surgeons (16)
  8. Breast Medicine Service (10)
  9. Center for Pancreatic Cancer Research (9)
  10. Colorectal Surgery (9)
Search Within
  1. "2002"
Formats
  1. Journal Article (67)
  2. Meeting Abstract (29)
  3. Book Section (1)
  4. Book Whole (1)
Groups
  1. Surgery (46)
  2. Survivorship Research (33)
  3. Department of Medicine (29)
  4. Solid Tumor Oncology Division (20)
  5. Sloan Kettering Institute Faculty (19)
  6. Molecular Pharmacology and Chemistry Program Faculty (16)

More Groups

People
  1. Murray Brennan (15)
  2. Daniel Coit (9)
  3. Kevin Conlon (9)
  4. Clifford Hudis (8)
  5. Philip Paty (8)
  6. Yuman Fong (7)

More People

Years
  1. 2002 (98)
Publications
  1. Annals of Surgical Oncology (37)
  2. Breast Cancer Research and Treatment (13)
  3. Current Oncology Reports (7)
  4. Journal of Endocrinological Investigation (4)
  5. Journal of Gastrointestinal Surgery (4)
  6. Cancer Chemotherapy and Pharmacology (2)

More Publications

Results (98)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone mineral density and hormone receptor status in patients with newly diagnosed breast cancer, a retrospective assessment
    Meeting Abstract

    Van Poznak, C. H.; Howard, J. E.; Seidman, A. D.; Norton, L.; Hudis, C.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Monitoring clinical response to trastuzumab (Herceptin) therapy based on measurements of serum HER-2/neu in metastatic breast cancer
    Meeting Abstract

    Schwartz, M. K.; Ghani, F.; Kish, L. A.; Dnistrian, A. M.; Schwartz, D. C.; Lin, D.; Armstrong, G.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Utility of biopotentials measured with the Biofield Diagnostic System for distinguishing malignant from benign lesions and proliferative from nonproliferative benign lesions
    Meeting Abstract

    Sacchini, V.; Gatzemeier, W.; Costa, A.; Merson, M.; Bonanni, B.; Gennaro; Zandonini, G.; Gennari, R.; Holland, R.; Schreer, I.; more...
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Impact of tamoxifen on the risk of metachronous contralateral breast cancer in women with germline mutations of BRCA1 or BRCA2
    Meeting Abstract

    Robson, M. E.; Satagopan, J.; Hudis, C. A.; Boyd, J.; Offit, K.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Effect of creatinine clearance (CrCl) on patterns of toxicity in breast cancer (BC) patients (pts) age 65 and older receiving adjuvant chemotherapy
    Meeting Abstract

    Hurria, A.; Panageas, K.; Brogan, K.; Norton, L.; Howard, J.; Hudis, C.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Final report: Epoetin alfa maintains hemoglobin levels and quality of life in breast cancer patients during conventional adjuvant chemotherapy
    Meeting Abstract

    Hudis, C.; Williams, D.; Gralow, J.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Incidence of amenorrhea (A) in breast cancer (BC) patients (pts) <= 40 years of age after paclitaxel (T)-based adjuvant chemotherapy (CT)
    Meeting Abstract

    Fornier, M. N.; Modi, S.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Schwartz, M. K.; Panageas, K. S.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Monitoring serum HER-2/neu levels in metastatic breast cancer patients undergoing Herceptin (R) therapy regimens
    Meeting Abstract

    Brown-Shimer, S. L.; Schwartz, M. K.; Schwartz, D.; Lin, D.; Carney, W. P.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Open-label, phase II, multicenter trial of ZD1839 ('Iressa') in patients with advanced breast cancer
    Meeting Abstract

    Albain, K.; Elledge, R.; Gradishar, W. J.; Hayes, D. F.; Rowinsky, E.; Hudis, C.; Pusztai, L.; Tripathy, D.; Modi, S.; Rubi, S.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save